Vonjo Interactions
There are 724 drugs known to interact with Vonjo (pacritinib), along with 7 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 323 are major, 395 are moderate, and 6 are minor.
- View all 724 medications that may interact with Vonjo
- View Vonjo alcohol/food interactions (2)
- View Vonjo disease interactions (7)
Most frequently checked interactions
View interaction reports for Vonjo (pacritinib) and the medicines listed below.
- Advil (ibuprofen)
- allopurinol
- atorvastatin
- azithromycin
- Benadryl (diphenhydramine)
- Bystolic (nebivolol)
- calcium carbonate
- calcium / vitamin d
- Capzasin-HP (capsaicin topical)
- Clenpiq (citric acid/magnesium oxide/sodium picosulfate)
- clindamycin
- Daily Multi-Vitamins with Minerals (multivitamin with minerals)
- danazol
- Darzalex Faspro (daratumumab / hyaluronidase)
- dexamethasone
- Diovan HCT (hydrochlorothiazide / valsartan)
- Doptelet (avatrombopag)
- doxazosin
- doxycycline
- estradiol topical
- famciclovir
- fentanyl
- ferrous fumarate
- fluoride topical
- folic acid
- furosemide
- gabapentin
- glimepiride
- Imodium (loperamide)
- metformin
Vonjo alcohol/food interactions
There are 2 alcohol/food interactions with Vonjo (pacritinib).
Vonjo disease interactions
There are 7 disease interactions with Vonjo (pacritinib) which include:
- cardiovascular risk
- malignancy
- thrombosis
- Pacritinib-diarrhea
- Pacritinib-infection
- Pacritinib-hemorrhage
- Pacritinib-QT prolongation
Report options
QR code containing a link to this page
More about Vonjo (pacritinib)
- Vonjo consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
